Sold to Unchained Labs in 2017

Trinean is an IMEC/UGhent spin-off that provides small volume and high throughput solutions for measurement applications in the life science industry. The company commercializes the first µL micro-plate reader for bio-molecule quantification (DNA, RNA…) with an extension to other future applications such as physico-chemical testing and enzyme assays.

Responsible: Marc Wachsmuth

News about
EMQN integrates Trinean’s DropSense™
Freeslate Integrates the DropSense96TM
UK Biobank selects Trinean’s DropSense96TM
Trinean to appoint Chris Van Ingen as member of the board
Trinean to enter into global supply agreement with QIAGEN
Trinean signs a global agreement with Bayer CropScience
Trinean launches the Xpose, a new micro-volume spectrophotometer
Trinean included in the ISBER Proficiency testing program
Trinean appoints new CEO and secures 2.7 million euro financing
Capital-E invests an additional 1.3 million € in Trinian nv

Overview portfolio